Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 45 announcements

Share price
₹235.99
Market cap
₹1,557 Cr
Revenue (annual)
₹287.2 Cr
Net profit (annual)
₹43.08 Cr
P/E (TTM)
34.2×Sector 47.4×
Promoter holding
69.05%+1.16% QoQ
FII holding
2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:12 IST BSE
Financial Results

Jagsonpal Pharmaceuticals Financial Results

Jagsonpal Pharmaceuticals reported FY26 total income of ₹299.22 Crore and Net Profit of ₹43.08 Crore. The Board recommended a dividend of ₹4 (200%) per equity share. Additionally, a buy-back of up to 16,00,000 equity shares at ₹250 per share was previously approved, totaling ₹40 Crore.